First reports of adverse drug reactions (ADRs) in recent weeks

January 2004
Drugs & Therapy Perspectives;Jan2004, Vol. 20 Issue 1, p19
Academic Journal
Presents a table that contains an overview of first published case reports of adverse drug reactions identified in the international literature in recent weeks by the drug safety alerting service "Reactions Weekly." Amlodipine overdose; Anagrelide overdose; Anagrelide overdose.


Related Articles

  • Adverse drug reaction reporting--1996. Wray, Claire-Marie // CMAJ: Canadian Medical Association Journal;04/01/97, Vol. 156 Issue 7, p1054 

    Focuses on adverse drug reaction (ADR) reporting to the Canadian Adverse Drug Reaction Monitoring Program in 1996. Number of spontaneous case reports submitted; Aim of increasing awareness and participation in ADR reporting in various regions in the country.

  • Amlodipine overdose.  // Reactions Weekly;Dec2014, Vol. 1532 Issue 1, p27 

    The article presents a case report of a 16-year old boy who developed distributive shock following an intentional overdose of amlodipine.

  • Down side of drug therapy--adverse reactions, Rx errors a greater role for industry?  // Medical Marketing & Media;Feb98, Vol. 33 Issue 2, p16 

    Reports on increased frequency of adverse drug reactions and medication prescribing errors among hospitalized patients as reported in current medical journals. Drug-associated fatalities in surgical inpatients and medical inpatients; Suggested remedies for drug-associated fatalities; Role of...

  • Resistance to compulsory drugs reaction reports.  // Nursing Standard;2/9/2005, Vol. 19 Issue 22, p7 

    Reports on the rejection of the Ministers on the demands for compulsory reporting of adverse drug reactions in Great Britain.

  • Amlodipine/verapamil overdose.  // Reactions Weekly;3/7/2009, Issue 1242, p7 

    The article describes the cases of two patients who experienced cardiovascular collapse following an overdosage of verapamil and amlodipine. A 47-year-old woman ingested 16 grams of verapamil and her arterial blood showed severe metabolic acidosis and lactataemia. A 38-year-old man was found...

  • Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisininbased combination therapy, to the WHO Programme for International Drug Monitoring. Kuemmerle, Andrea; Dodoo, Alex N. O.; Olsson, Sten; Van Erps, Jan; Burri, Christian; Lalvani, Paul S. // Malaria Journal;2011, Vol. 10 Issue 1, p57 

    Background: In spite of enhanced control efforts, malaria remains a major public health problem causing close to a million deaths annually. With support from several donors, large amounts of artemisinin-based combination therapy (ACT) are being deployed in endemic countries raising safety...

  • ICH spontaneous ADR reporting proposal. Dickinson, James G. // Medical Marketing & Media;Sep97, Vol. 32 Issue 9, p30 

    Reports on the Pharmaceutical Research and Manufacturers of America's proposal that drug companies should only report medically confirmed spontaneous reports or those reactions for which consumers have sought medical treatment and the attending physician agrees were drug-related.

  • FDA field targets ADR submissions. James G., Dickinson // Medical Marketing & Media;Oct97, Vol. 32 Issue 10, p30 

    Reports on the US Food and Drug Administration field compliance program for drug firms with a history of adverse drug reaction reporting problems. Examination of completion and accuracy of ADR submissions; Internet address of the compliance program.

  • FDA: STUDY SUGGESTS MORE DTC NEGATIVE INFO; RELENZA PROMISED TOO MUCH. Dickinson, James G. // Medical Marketing & Media;Mar2000, Vol. 35 Issue 3, p36 

    Presents pharmaceutical industry-related news items, compiled in March 2000. Includes public concerns over the inadequacy of negative information about drugs in direct-to-consumer advertisements; Pharmaceutical companies' opportunities to sponsor segment on the consumer side of eMD.com; Cost...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics